EMMA GOEBEL: Open Payments
NPI 1679204390 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 59 payments from 7 companies in 2025. Trend: 2023 $261 · 2024 $455 · 2025 $922
Food & beverage: $721Education: $201
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 44 | $511 |
| Verona Pharma, Inc. | 6 | $107 |
| HARMONY BIOSCIENCES LLC | 1 | $88 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| United Therapeutics Corporation | 3 | $54 |
| Insmed, Inc. | 3 | $50 |
| Amgen Inc. | 1 | $34 |
Products named: NUCALA, Ohtuvayre, DUPIXENT, Arikayce, TRELEGY ELLIPTA, Tyvaso.
Industry payments across NJ — which companies pay providers there.
